Clinical efficacy of low-dose Prednisone combined with Tacrolimus in children with refractory nephrotic syndrome
10.13431/j.cnki.immunol.j.20250114
- VernacularTitle:小剂量泼尼松联合他克莫司对难治性肾病综合征患儿的临床疗效探究
- Author:
Chao ZHONG
1
;
Yulian MO
1
;
Xueli WEI
1
;
Xiangfeng XU
1
;
Rixiang LIAO
1
Author Information
1. 桂林医学院第二附属医院儿科,广西壮族自治区 桂林 541199
- Publication Type:Journal Article
- Keywords:
refractory nephrotic syndrome;
child;
Prednisone;
Tacrolimus;
injury of kidney;
microcirculation
- From:
Immunological Journal
2025;41(11):824-829
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical efficacy of low-dose Prednisone combined with Tacrolimus in children with refractory nephrotic syndrome(RNS).Methods A total of 106 children with RNS admitted from March 2022 to September 2023 were included and evenly divided into the monotherapy group and the combination therapy group according to the random number table method.The monotherapy group was given low-dose Prednisone tablets,while the combination therapy group was given low-dose Prednisone tablets combined with Tacrolimus.The differences in nailfold microcirculation indicators,lipid metabolism indicators,renal injury markers,clinical efficacy,and adverse reactions were compared between the two groups.Results The total effective rate of the combination therapy group was higher than that of the monotherapy group(P<0.05).At 3 months after treatment,the serum albumin,capillary flow velocity,input branch diameter and output branch diameter in the combination therapy group were all higher than those in the monotherapy group,while the levels of red blood cell aggregation,triglycerides,low-density lipoprotein cholesterol,total cholesterol,serum creatinine,24-hour urine protein quantification,neutrophil gelatin enzyme-associated lipocalin,retinol binding protein,α1-microglobulin,β-N-acetylglucosaminidase,and renal injury molecule-1 were all lower than those in the monotherapy group(P<0.05).The total incidence of adverse reactions in the combination therapy group was lower than that in the monotherapy group(P<0.05).Conclusion In the treatment of children with RNS,the combination of Tacrolimus and low-dose Prednisone can improve the microcirculation status and reduce renal injury markers,with remarkable effects.
